RARRES2 and chronic kidney disease: Pooling of the eight studies comparing CKD in any stage and healthy controls revealed significantly higher chemerin levels in CKD patients (SMD [95% CI]: 2.15 [0.83, 3.48], p-value <0.01, Figure 2).